Palatin Technologies, Inc. (PTN)
NCM – Real Time Price. Currency in USD
11.44
+0.98 (9.37%)
At close: Jun 26, 2026, 4:00 PM EDT
12.00
+0.56 (4.90%)
After-hours: Jun 26, 2026, 4:41 PM EDT
Find any stock by ticker or company name

NCM – Real Time Price. Currency in USD
11.44
+0.98 (9.37%)
At close: Jun 26, 2026, 4:00 PM EDT
12.00
+0.56 (4.90%)
After-hours: Jun 26, 2026, 4:41 PM EDT
Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 MC4R agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity in Phase 2 trial, as well as Bremelanotide co-formulated with a PDE5i for the treatment of ED in patients not adequately responsive to PDE5i monotherapy. The company also develops PL9643 for dry eye disease and anti-inflammatory ocular indications; and oral PL8177 for the treatment inflammatory bowel diseases. Palatin Technologies, Inc. was incorporated in 1986 and is based in Monmouth Junction, New Jersey.
| Name | Position |
|---|---|
| Burns McClellan | Vice President of Investor Relations |
| Dr. Carl Spana Ph.D. | Co-Founder, President, CEO & Director |
| Mr. James E. Hattersley B.A., M.S. | Senior Vice President of Business Development |
| Mr. John Dodd Ph.D. | Senior Vice President of Preclinical Development |
| Mr. Robert Jordan | Senior Vice President of Program Operations |
| Mr. Stephen A. Slusher Esq. | Chief Legal Officer |
| Mr. Stephen T. Wills CPA, MST | CFO, COO, Executive VP, Treasurer & Secretary |
| Date | Type | Document |
|---|---|---|
| 2026-06-25 | DEF 14A | formdef14a.htm |
| 2026-05-28 | 8-A12B | form8-a12b.htm |
| 2026-05-28 | 25 | form25.htm |
| 2026-05-18 | 8-K | form8-k.htm |
| 2026-05-13 | 10-Q | form10-q.htm |
| 2026-02-17 | 10-Q | form10-q.htm |
| 2025-12-19 | 8-K/A | form8-ka.htm |
| 2025-11-14 | 10-Q | ptn_10q.htm |
| 2025-11-12 | 8-K | ptn_8k.htm |
| 2025-11-06 | 8-K | ptn_8k.htm |